Journal List > Korean J Urol > v.49(7) > 1005143

Park, Yu, Sung, Chung, and Noh: Suprapubic Arch Procedure for the Treatment of Urinary Incontinence in Elderly Female Patients

Abstract

Purpose

There has been considerable controversy regarding the treatment of urinary incontinence (UI). The aim of our study was to investigate the efficacy and safety of the suprapubic arch (SPARC) procedure for the management of UI in elderly women.

Materials and Methods

A retrospective analysis was conducted on 301 women who underwent the SPARC procedure for SUI. The patients were divided into two groups: group A (<65 years) and group B (≥65 years). Among these patients, women with mixed urinary incontinence (MUI) were assigned to either group C (<65 years) or group D (≥65 years). The objective and subjective SPARC success rates were evaluated postoperatively.

Results

There were 258 patients in group A, 43 patients in group B, 44 patients in group C, and 11 patients in group D. The objective surgical success rates for groups A and B were 97.7% and 95.3%, respectively (p=0.304). The subjective success rates for groups A and B were 97.3% and 95.3%, respectively (p=0.311). Recommendation rates for the SPARC procedure were 93% in group A and 93% in group B (p=0.5). In patients with MUI (groups C and D), the objective success rates were 93.2% (group C) and 81.8% (group D) (p=0.286). The subjective success rates were 93.2% (group C) and 81.8% (group D) (p=0.286). The complication rates were similar between the two study groups: 5.4% (group A) vs 7.0% (group B) (p=0.359).

Conclusions

The SPARC procedure is effective and safe, and it offers a satisfactory success rate in elderly women with UI.

REFERENCES

1.Ulmsten U., Henriksson L., Johnson P., Varhos G. An ambulatory surgical procedure under local anesthesia for treatment of female urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 1996. 7:81–6.
crossref
2.Andonian S., Chen T., St-Denis B., Corcos J. Randomized clinical trial comparing suprapubic arch sling (SPARC) and tension-free vaginal tape (TVT): one-year results. Eur Urol. 2005. 47:537–41.
crossref
3.Stamey TA. Endoscopic suspension of the vesical neck for urinary incontinence in females. Report on 203 consecutive patients. Ann Surg. 1980. 192:465–9.
4.Homma Y. Lower urinary tract symptomatology: its definition and confusion. Int J Urol. 2008. 15:35–43.
crossref
5.Choo MS., Ku JH., Oh SJ., Lee KS., Paick JS., Seo JT, et al. Prevalence of urinary incontinence in Korean women: an epidemiologic survey. Int Urogynecol J Pelvic Floor Dysfunct. 2007. 18:1309–15.
6.Petros PE., Ulmsten UI. An integral theory and its method for the diagnosis and management of female urinary incontinence. Scand J Urol Nephrol. 1993. 153(Suppl):1–93.
7.Nilsson CG., Kuuva N., Falconer C., Rezapour M., Ulmsten U. Long-term results of the tension-free vaginal tape (TVT) procedure for surgical treatment of female stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2001. 12(Suppl 2):5–8.
crossref
8.Kobashi KC., Govier FE. Perioperative complications: the first 140 polyprolene pubovaginal slings. J Urol. 2003. 170:1918–21.
9.Na W., Lee JB. The results of performing the SPARC procedure for treating female stress urinary incontinence: a 14 month study. Korean J Urol. 2006. 47:734–9.
crossref
10.Ulmsten U., Falconer C., Johnson P., Jomaa M., Lanner L., Nilsson CG, et al. A multicenter study of tension-free vaginal tape (TVT) for surgical treatment of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 1998. 9:210–3.
crossref
11.Siddiqui K., Grainger R. Preliminary experience with SPARC pubovaginal sling in treatment of female stress urinary incontinence. BJU Int. 2004. 94(Suppl 2):252–3. abstract 3.
12.Primus G. SPARC-sling system for the treatment of female urodynamic stress urinary incontinence an unicenter prospective study with 2 years follow-up. BJU Int. 2004. 94(Suppl 2):): 250, abstract 13.
13.Nazemi TM., Yamada B., Govier FE., Kuznetsov DD., Kodama K., Kobashi KC. Minimum 24-month followup of the sling for the treatment of stress urinary incontinence. J Urol. 2008. 179:596–9.
crossref
14.Deval B., Levardon M., Samain E., Rafii A., Cortesse A., Amarenco G, et al. A French multicenter clinical trial of SPARC for stress urinary incontinence. Eur Urol. 2003. 44:254–9.
crossref
15.Anger JT., Litwin MS., Wang Q., Pashos CL., Rodríguez LV. The effect of age on outcomes of sling surgery for urinary incontinence. J Am Geriatr Soc. 2007. 55:1927–31.
crossref
16.Dalpiaz O., Primus G., Schips L. SPARC sling system for treatment of female stress urinary incontinence in the elderly. Eur Urol. 2006. 50:826–31.
crossref
17.Hodroff MA., Sutherland SE., Kesha JB., Siegel SW. Treatment of stress incontinence with the SPARC sling: intraoperative and early complications of 445 patients. Urology. 2005. 66:760–2.
crossref
18.Gordon D., Gold R., Pauzner D., Lessing JB., Groutz A. Tension-free vaginal tape in the elderly: is it a safe procedure? Urology. 2005. 65:479–82.
crossref

Table 1.
Characteristics of patients undergoing the suprapubic arch procedure
Variables Group A* (n=258) Group B (n=43) p-value
Parity (No.) 3.2±1.1 3.4±1.5 NS
Stamey grade
I 93 (36.0) 14 (32.5) NS
II 157 (60.9) 27 (62.8) NS
III 8 (3.1) 2 (4.7) NS
Anti-incontinence surgery (%) 13 (5.0) 2 (4.7) NS
Previous pelvic surgery (%) 81 (31.4) 15 (34.9) NS
Cystocele (%) 49 (19.0) 10 (23.3) NS
Q-max (ml/s) 31.6±2.3 28.9±1.9 NS
Post-void residual (ml) 25.8±5.9 29.1±6.4 NS
Valsalva leak point
pressure (cmH2O) 59.2±8.6 55.7±8.3 NS
1-hour pad test (g) 35.2±3.3 38.1±3.6 NS

* : age<65 years

: age≥65 years, NS: not significant

Table 2.
Objective and subjective success rates according to age group
Outcome Group A* (n=258) Group B (n=43) Total (n=301) p-value
Objective
Success (%) 252 (97.7) 41 (95.3) 293 (97.3) 0.304
Cure (%) 232 (89.9) 37 (86) 269 (89.3)
Improved (%) 20 (7.8) 4 (9.3) 24 (8)
Failure (%) 6 (2.3) 2 (4.7) 8 (2.7)
Subjective
Success (%) 251 (97.3) 41 (95.3) 292 (97) 0.311
Satisfied (%) 236 (91.5) 38 (88.4) 274 (91)
Fair (%) 15 (5.8) 3 (6.9) 18 (6)
Dissatisfied (%) 7 (2.7) 2 (4.7) 9 (3)

* : age<65 years

: age≥65 years

Table 3.
Objective and subjective success rates according to age group in mixed urinary incontinence patients
Outcome Group C* (n=44) Group D (n=11) Total (n=55) p-value
Objective
Success (%) 41 (93.2) 9 (81.8) 50 (90.9) 0.286
Cure (%) 35 (79.5) 8 (72.7) 43 (78.2)
Improved (%) 6 (13.6) 1 (9.1) 7 (12.7)
Failure (%) 3 (6.8) 2 (18.2) 5 (9.1)
Subjective
Success (%) 41 (93.2) 9 (81.8) 50 (90.9) 0.286
Satisfied (%) 36 (81.8) 8 (72.7) 44 (80)
Fair (%) 5 (11.4) 1 (9.1) 6 (10.9)
Dissatisfied (%) 3 (6.8) 2 (18.2) 5 (9.1)

* : age<65 years

: age≥65 years

TOOLS
Similar articles